BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9432488)

  • 1. [Current status of Helicobacter pylori eradication therapy. Significance of roxithromycin].
    Bock H; Mares A
    Fortschr Med; 1997 Sep; 115(27):54-5. PubMed ID: 9432488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
    Bock H; Mares A
    Leber Magen Darm; 1996 Sep; 26(5):268. PubMed ID: 9005302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two regimens on eradication of Helicobacter pylori.
    Rathi P; Sawant P; Gopanpallikar A
    J Assoc Physicians India; 2000 Aug; 48(8):852-3. PubMed ID: 11273492
    [No Abstract]   [Full Text] [Related]  

  • 7. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
    Kirstein FW; Epple HJ; Bojarski C; Victor L; Fromm M; Riecken EO; Schulzke JD
    Z Gastroenterol; 1998 Sep; 36(9):803-9. PubMed ID: 9795409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of Helicobacter pylori associated diseases].
    Bayerdörffer E
    Bildgebung; 1995 Apr; 62 Suppl 1():70-1. PubMed ID: 7670311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infections caused by Helicobacter pylori].
    Stock I; Wiedemann B
    Med Monatsschr Pharm; 1997 Jan; 20(1):2-8. PubMed ID: 9082155
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association.
    Lombardo L; Masoero G; Della Monica P; Pera A
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):266-7. PubMed ID: 10379493
    [No Abstract]   [Full Text] [Related]  

  • 12. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori infection.
    Delaney B; Moayyedi P; Forman D
    Clin Evid; 2002 Jun; (7):414-28. PubMed ID: 12230667
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].
    MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Helicobacter pylori--overview of therapy].
    Katicić M; Prskalo M; Tićak M; Sabarić B; Marusić M; Banić M; Buljevac M; Kujundzić M; Jelić D; Kozić M; Mihaljević S; Mićunović Z; Skurla B; Filipec T
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():72-8. PubMed ID: 12592823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endoscopy observation of patients with conducted eradication therapy of Helicobacter pylori in gastric and duodenal ulcer].
    Koval' AM; Nefedova EA; Pulik AV; Vyrova IuV
    Voen Med Zh; 2006 Jul; 327(7):28-33. PubMed ID: 16977878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is gastric acid secretion inhibition necessary for successful eradication of Helicobacter pylori?].
    Müller P; Simon B
    Fortschr Med; 1996 Aug; 114(22-23):275-6. PubMed ID: 8974962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.